These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 17669078)

  • 1. Duration of P-wave is associated with atrial fibrillation hospitalizations in patients with atrial fibrillation and paced for bradycardia.
    Padeletti L; Santini M; Boriani G; Botto G; Ricci R; Spampinato A; Vergara G; Rahue WG; Capucci A; Gulizia M; Pieragnoli P; Grammatico A; Platonov P; Barold SS
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):961-9. PubMed ID: 17669078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sinus and paced P wave duration and dispersion as predictors of atrial fibrillation after pacemaker implantation in patients with isolated sick sinus syndrome.
    Kristensen L; Nielsen JC; Mortensen PT; Christensen PD; Vesterlund T; Pedersen AK; Andersen HR
    Pacing Clin Electrophysiol; 2004 May; 27(5):606-14. PubMed ID: 15125716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
    De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
    Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.
    Capucci A; Santini M; Padeletti L; Gulizia M; Botto G; Boriani G; Ricci R; Favale S; Zolezzi F; Di Belardino N; Molon G; Drago F; Villani GQ; Mazzini E; Vimercati M; Grammatico A;
    J Am Coll Cardiol; 2005 Nov; 46(10):1913-20. PubMed ID: 16286180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial.
    Tsai CT; Lai LP; Hwang JJ; Wang YC; Chiang FT; Lin JL
    Am Heart J; 2008 Jul; 156(1):65-70. PubMed ID: 18585498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias.
    Saksena S; Hettrick DA; Koehler JL; Grammatico A; Padeletti L
    Am Heart J; 2007 Nov; 154(5):884-92. PubMed ID: 17967594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation.
    Gillis AM; Morck M; Exner DV; Soo A; Rose MS; Sheldon RS; Duff HJ; Kavanagh KM; Mitchell LB; Wyse DG
    Eur Heart J; 2008 Aug; 29(15):1873-80. PubMed ID: 18477727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of atrial fibrillation in patients with cardiac dysfunctions: P wave signal-averaged ECG and chemoreflexsensitivity in atrial fibrillation.
    Budeus M; Hennersdorf M; Felix O; Reimert K; Perings C; Wieneke H; Erbel R; Sack S
    Europace; 2007 Aug; 9(8):601-7. PubMed ID: 17507361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of spontaneous atrial fibrillation electrogram potentials with the P-wave electrogram amplitude in dual chamber pacing with unipolar atrial sensing.
    Lewalter T; Schimpf R; Kulik D; Wolpert C; Jung W; Lüderitz B
    Europace; 2000 Apr; 2(2):136-40. PubMed ID: 11227585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E; Saba S
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of an electropharmacological transesophageal test in the prevention of paroxysmal atrial fibrillation. Experience with flecainide].
    De Sisti A; Matteucci C; Patrissi T; Accogli S; Di Lorenzo M; Sasdelli M; Ciolli A; Lo Sardo G; Palamara A
    G Ital Cardiol; 1998 Dec; 28(12):1391-9. PubMed ID: 9887393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Greenspon AJ; Freedman RA; Lee KL; Lamas GA;
    Circulation; 2003 Jun; 107(23):2932-7. PubMed ID: 12782566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study.
    Camm AJ; Sulke N; Edvardsson N; Ritter P; Albers BA; Ruiter JH; Lewalter T; Capucci PA; Hoffmann E;
    Europace; 2007 Dec; 9(12):1110-8. PubMed ID: 18042619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation.
    Oliveira MM; da Silva N; Timóteo AT; Feliciano J; de Sousa L; Santos S; Marques F; Ferreira R
    Rev Port Cardiol; 2007; 26(7-8):691-702. PubMed ID: 17939579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
    De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Septal atrial pacing for the prevention of atrial fibrillation.
    Hakacova N; Velimirovic D; Margitfalvi P; Hatala R; Buckingham TA
    Europace; 2007 Dec; 9(12):1124-8. PubMed ID: 18024494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
    Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method of multisite atrial pacing, incorporating Bachmann's bundle area and coronary sinus ostium, for electrical atrial resynchronization in patients with recurrent atrial fibrillation.
    Lewicka-Nowak E; Kutarski A; Dabrowska-Kugacka A; Rucinski P; Zagozdzon P; Raczak G
    Europace; 2007 Sep; 9(9):805-11. PubMed ID: 17670780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.
    Connolly SJ; Kerr CR; Gent M; Roberts RS; Yusuf S; Gillis AM; Sami MH; Talajic M; Tang AS; Klein GJ; Lau C; Newman DM
    N Engl J Med; 2000 May; 342(19):1385-91. PubMed ID: 10805823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of electrical remodeling in human atrial fibrillation: results of the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial mechanisms of atrial fibrillation study.
    Healey JS; Israel CW; Connolly SJ; Hohnloser SH; Nair GM; Divakaramenon S; Capucci A; Van Gelder IC; Lau CP; Gold MR; Carlson M; Themeles E; Morillo CA
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):626-31. PubMed ID: 22670051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.